Moving towards making (quantitative) structure-activity relationships ((Q)SARs) for toxicity-related endpoints findable, accessible, interoperable and reusable (FAIR)
(Quantitative) structure-activity relationships ((Q)SARs) are widely used in chemical safety assessment to predict toxicological effects. Many thousands of (Q)SAR models have been developed and published, however, few are easily available to use. This investigation has applied previously developed Findability, Accessibility, Interoperability, and Reuse (FAIR) Principles for in silico models to six published, different, machine learning (ML) (Q)SARs for the same toxicity dataset (inhibition of growth to Tetrahymena pyriformis). The majority of principles were met, however, there are still gaps in making (Q)SARs FAIR. This study has enabled insights into, and recommendations for, the FAIRification of (Q)SARs including areas where more work and effort may be required. For instance, there is still a need for (Q)SARs to be associated with a unique identifier and full data / metadata for toxicological activity or endpoints, molecular properties and descriptors, as well as model description to be provided in a standardised manner. A number of solutions to the challenges were identified, such as building on the QSAR Model Reporting Format (QMRF) and the application of QSAR Assessment Framework (QAF). This study also demonstrated that resources such as the QSAR Databank (QsarDB, www.qsardb.org) are valuable in storing ML QSARs in a searchable database and also provide a Digital Object Identifier (DOI). Many activities related to FAIR are currently underway and (Q)SAR modellers should be encouraged to utilise these to move towards the easier access and use of models. Enabling FAIR computational toxicology models will support the overall progress towards animal free chemical safety assessment.
Authors
- Samuel J. Belfield (ORCID: https://orcid.org/0000-0002-6532-2532)
- Eva Bay Wedebye (ORCID: https://orcid.org/0000-0002-2848-3273)
- Sulev Sild (ORCID: https://orcid.org/0000-0002-8189-4370)
- Anish Gomatam (ORCID: https://orcid.org/0000-0002-7473-0108)
- James W. Firman (ORCID: https://orcid.org/0000-0003-0319-1407)
- Aljŏs̆a Smajíć (ORCID: https://orcid.org/0000-0002-0847-3860)
- Hassan Basiri (ORCID: https://orcid.org/0000-0001-6571-706X)
- Swapnil Chavan (ORCID: https://orcid.org/0000-0003-4158-4148)
- Uko Maran (ORCID: https://orcid.org/0000-0003-2506-0934)
- Nikolai Georgiev Nikolov (ORCID: https://orcid.org/0000-0002-9212-9201)
- Geven Piir (ORCID: https://orcid.org/0000-0002-7381-2689)
- M Cronin (ORCID: https://orcid.org/0000-0002-6207-4158)
- E. Vila (ORCID: https://orcid.org/0000-0002-3161-1213)
- Judith C. Madden (ORCID: https://orcid.org/0000-0001-6142-5860)
- Manuel Pastor (ORCID: https://orcid.org/0000-0001-8850-1341)
- Nicoleta Sp̂înu (ORCID: https://orcid.org/0000-0002-9465-3090)
- Steven J. Enoch (ORCID: https://orcid.org/0000-0001-9111-5783)
- Palle Steen Helmke (ORCID: https://orcid.org/0009-0003-8393-9047)
- Barry Hardy
- Georgios Chrysochoou
Institutions
- University of Vienna (AT)
- Universitat Pompeu Fabra (ES)
- RISE Research Institutes of Sweden (SE)
- University of Manchester (GB)
- Edelweiss Connect (Switzerland) (CH)
- University of Tartu (EE)
- Liverpool John Moores University (GB)
Publication Details
- Journal
- ALTEX
- Published
- 2025-01-01
- DOI
- https://doi.org/10.14573/altex.2411161
- Citations
- 2
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 3.01
Funders
- European Commission
- Eesti Teadusagentuur
- HORIZON EUROPE Framework Programme